Thalidomide
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Thalidomide and local guidelines before prescribing.
Mechanism
Immunomodulator with anti-angiogenic and TNF-lowering effects.
Uses
Multiple myeloma, erythema nodosum leprosum.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Teratogenicity, peripheral neuropathy, VTE, drowsiness, constipation.
Interactions
Sedatives additive; hormonal contraceptives increase VTE risk.
Contraindications and cautions
Pregnancy, women of childbearing potential without programme, neuropathy
Monitoring
Pregnancy test, FBC, neuropathy
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Caution in renal impairment
Overdose and reversal
Supportive
Special advice
Pregnancy prevention programme; thromboprophylaxis; neuropathy review.
More from the textbook: uses, cautions and other points
- Lenalidomide , thalidomide, pomalidomide (immunomodulatory) | Myeloma , myelodysplasia | Teratogenic - Pregnancy Prevention Programme; VTE (thromboprophylaxis); neuropathy (thalidomide), marrow suppression (lenalidomide)
Haematology: Anatomy Physiology and Pharmacology - Myeloma supportive care - bisphosphonates (zoledronic acid - jaw osteonecrosis, kidney checks), treat hypercalcaemia and kidney injury, VTE prophylaxis with lenalidomide or thalidomide, vaccines, infection prophylaxis.
Haematology: Anatomy Physiology and Pharmacology - Rasburicase is contraindicated in G6PD deficiency; lenalidomide and thalidomide need VTE prophylaxis and pregnancy prevention.
Haematology: Anatomy Physiology and Pharmacology - Thromboprophylaxis with thalidomide, lenalidomide or pomalidomide (aspirin or an anticoagulant according to risk).
Haematology: Myeloma and Lymphoma - Chemotherapy - vincristine, platinum drugs, taxanes, bortezomib, thalidomide.
Neurology: Neuromuscular disease - Thrombosis | Combined pill , oral HRT , tamoxifen and raloxifene, thalidomide and lenalidomide , ESAs, JAK inhibitors, asparaginase, tranexamic acid (if pre-existing clot risk), testosterone (via polycythaemia), antipsychotics, steroids, ponatinib
Haematology: Anatomy Physiology and Pharmacology - MHRA Drug Safety Updates: DOACs in antiphospholipid syndrome, IV iron, lenalidomide and thalidomide, clozapine
Haematology: Anatomy Physiology and Pharmacology - Clotting - combined pill, HRT, tamoxifen, testosterone, thalidomide or lenalidomide.
Haematology: History and Examination
Where it is discussed in the book
- Neurology: Neuromuscular disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (5 mentions)
- Haematology: History and Examination (2 mentions)
- Haematology: Myeloma and Lymphoma (4 mentions)
- Obstetrics (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- 0203 (1 mention)
- Anatomy: Embryology and development (2 mentions)
- 0240-embryology-and-congenital-anatomy (2 mentions)